Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+1
Study on Sacituzumab Govitecan for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer Resistant to Hormone and CDK4/6 Inhibitors
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients
Not recruiting
Investigated Diseases:Investigated Drugs:
+2
Study on Pembrolizumab and Paclitaxel for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer in Patients Resistant to CDK 4/6 Inhibitors
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Patritumab Deruxtecan with or without Endocrine Therapy for High-Risk HR+/HER2- Early Breast Cancer in Untreated Patients
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
+2
Study on Giredestrant or Tamoxifen for Premenopausal Women with Early ER-Positive, HER2-Negative Breast Cancer
Not recruiting
Investigated Diseases:Investigated Drugs:
Study on the Effect of Tamoxifen and Chemotherapy in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer with Low Recurrence Scores
Not recruiting
Investigated Diseases:Investigated Drugs:
Study of BT8009 for Patients with Advanced Breast Cancer with NECTIN4 Amplification
Not recruiting
Investigated Diseases:Investigated Drugs: